STOCK SYMBOL: IPIX
Formerly Cellceutix Corporation, we have re-branded ourselves as Innovation Pharmaceuticals Inc.
Join us as we continue to advance innovative medical therapies toward potential market approval.
“We are pleased to announce to shareholders, and the public at large, this important corporate development. With topline results from key clinical trials approaching, we believe Innovation Pharmaceuticals accurately describes the truly innovative nature of our first-in-class pipeline of mid-stage drug candidates. Our re-branding also better reflects the strategic positioning of the company as we move into the latter half of 2017, and beyond, looking to structure partnerships and joint-ventures should such opportunities present themselves.”
Leo Ehrlich, Chief Executive OfficerInnovation Pharmaceuticals Inc.